AnaCardio
AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Stockholm, Swedenwww.anacardio.com ↗
Total raised
€14M
€14,069,647
Funding rounds
1
Investors
5
distinct backers
Active since
2022-09
latest 2022-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-09 | Series A | €14M | 3B Health Ventures,Flerie Invest,Fredrik and Ann-Helene Ljungström,Industrifonden,Karolinska Development | View deal → |